Trial Search Results

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The purpose of this trial is to determine if using abdominal nerve blocks when patient undergo breast reconstruction can significantly decrease use of pain medications after reconstructive surgery.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Procedure: TAP block
  • Device: Nimbus Infusion Pump IV Administration
  • Drug: bupivacaine infusion
  • Drug: acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron


Phase 3


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer or undergoing prophylactic

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

   - True allergy to local anesthetics or opioids.

   - History of addiction to narcotics within the last 24 months

   - History of chronic pain on opioids within the last 24 months.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Afaaf Shakir